ZA202208630B - Use of pharmaceutical composition for preventing and treating novel coronavirus pneumonia - Google Patents
Use of pharmaceutical composition for preventing and treating novel coronavirus pneumoniaInfo
- Publication number
- ZA202208630B ZA202208630B ZA2022/08630A ZA202208630A ZA202208630B ZA 202208630 B ZA202208630 B ZA 202208630B ZA 2022/08630 A ZA2022/08630 A ZA 2022/08630A ZA 202208630 A ZA202208630 A ZA 202208630A ZA 202208630 B ZA202208630 B ZA 202208630B
- Authority
- ZA
- South Africa
- Prior art keywords
- preventing
- pharmaceutical composition
- novel coronavirus
- coronavirus pneumonia
- treating novel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010079857 | 2020-02-04 | ||
CN202010094502 | 2020-02-16 | ||
CN202010105903 | 2020-02-21 | ||
CN202010134508.6A CN112076262B (en) | 2020-02-04 | 2020-03-02 | Application of traditional Chinese medicine composition in preparation of medicine for preventing and treating novel coronavirus infection pneumonia |
PCT/CN2021/074783 WO2021155777A1 (en) | 2020-02-04 | 2021-02-02 | Use of pharmaceutical composition for preventing and treating novel coronavirus pneumonia |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA202208630B true ZA202208630B (en) | 2022-12-21 |
Family
ID=73734751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2022/08630A ZA202208630B (en) | 2020-02-04 | 2022-07-29 | Use of pharmaceutical composition for preventing and treating novel coronavirus pneumonia |
Country Status (4)
Country | Link |
---|---|
CN (3) | CN113476524A (en) |
CA (1) | CA3166282A1 (en) |
WO (1) | WO2021155777A1 (en) |
ZA (1) | ZA202208630B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113476524A (en) * | 2020-02-04 | 2021-10-08 | 石家庄以岭药业股份有限公司 | Application of traditional Chinese medicine composition in preparation of medicine for inhibiting increase of cytokines and chemokines of new coronavirus infection pneumonia patient |
CN114732853A (en) * | 2021-01-07 | 2022-07-12 | 石家庄以岭药业股份有限公司 | Application of Chinese medicinal composition in preparing medicine for resisting coronavirus, protecting viscera and enhancing immunity |
CN115317542A (en) * | 2021-05-11 | 2022-11-11 | 河北以岭医药研究院有限公司 | Application of traditional Chinese medicine composition in preparation of S protein D614G resistant mutant type new coronavirus medicines |
CN114748548A (en) * | 2022-05-06 | 2022-07-15 | 帝龙科技(中山)有限公司 | A Chinese medicinal composition for preventing and treating diseases caused by coronavirus |
CN115410645B (en) * | 2022-08-23 | 2023-07-21 | 北京泽桥医疗科技股份有限公司 | Method for identifying action target point of Chinese patent medicine for treating new coronaries pneumonia |
CN116236550A (en) * | 2023-02-07 | 2023-06-09 | 曾钟德 | Light traditional Chinese medicine formula preparation for treating novel coronavirus infection and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1194752C (en) * | 2003-07-01 | 2005-03-30 | 河北以岭医药研究院有限公司 | Anti-virus Chinese medicine composition and preparation process thereof |
CN105079226A (en) * | 2014-05-22 | 2015-11-25 | 北京以岭药业有限公司 | Application of traditional Chinese medicine composition to preparation of drug for resisting Middle East respiratory syndrome corona-virus (MERS-CoV) |
CN113476524A (en) * | 2020-02-04 | 2021-10-08 | 石家庄以岭药业股份有限公司 | Application of traditional Chinese medicine composition in preparation of medicine for inhibiting increase of cytokines and chemokines of new coronavirus infection pneumonia patient |
-
2020
- 2020-03-02 CN CN202110952216.8A patent/CN113476524A/en not_active Withdrawn
- 2020-03-02 CN CN202110952211.5A patent/CN113476523A/en not_active Withdrawn
- 2020-03-02 CN CN202010134508.6A patent/CN112076262B/en active Active
-
2021
- 2021-02-02 CA CA3166282A patent/CA3166282A1/en active Pending
- 2021-02-02 WO PCT/CN2021/074783 patent/WO2021155777A1/en active Application Filing
-
2022
- 2022-07-29 ZA ZA2022/08630A patent/ZA202208630B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN113476524A (en) | 2021-10-08 |
WO2021155777A1 (en) | 2021-08-12 |
CN113476523A (en) | 2021-10-08 |
CN112076262B (en) | 2021-09-17 |
CN112076262A (en) | 2020-12-15 |
CA3166282A1 (en) | 2021-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202208630B (en) | Use of pharmaceutical composition for preventing and treating novel coronavirus pneumonia | |
IL277315B (en) | Methods and composition for treating coronavirus infection | |
IL311331A (en) | Pharmaceutical composition and use thereof | |
IL308221A (en) | Compositions and methods for the treatment of depression | |
EP4168900A4 (en) | Compositions for supplementing products with therapeutic agents and methods of use thereof | |
EP4003332A4 (en) | Pharmaceutical composition of mdm2 inhibitor and use thereof for preventing and/or treating disease | |
IL312874A (en) | Pharmaceutical composition and use thereof | |
EP4171606A4 (en) | Compositions and methods for the treatment of covid-19 | |
GB202319843D0 (en) | CAS13-based compositions and methods of use thereof | |
EP4157255A4 (en) | Treatment of coronavirus | |
EP4162951A4 (en) | Pharmaceutical composition of enzymes and viruses and application thereof | |
IL307872A (en) | Novel compositions and methods for treating coronavirus infections | |
EP3960167A4 (en) | Use of pantothenic acid in preparation composition for treating and/or preventing tumors | |
ZA202210585B (en) | Parapoxvirus for conditioning for and treatment of coronavirus infections | |
EP4103192A4 (en) | Compositions and methods for treating coronavirus infections | |
IL312583A (en) | Composition for treatment and prevention of covid-19 | |
IL276627A (en) | Compositions for diagnosis and treatment of coronavirus infections | |
GB202103578D0 (en) | Prevention and treatment of infections including those caused by coronavirus | |
EP4190323A4 (en) | Composition for prevention and treatment of myopathy | |
GB2607584B (en) | Composition and method of treatment | |
HUP2200147A1 (en) | Pharmaceutical composition comprising palbociclib and letrozole | |
GB202317378D0 (en) | Composition and methods of treatment | |
EP4237094A4 (en) | Pharmaceutical compositions and methods of using the same for treating cancer | |
HUP2000425A1 (en) | Pharmaceutical composition for use prevention and/or treatment of illnesses caused by bacterial or viral infections | |
EP3932398A4 (en) | Pharmaceutical composition of single dosage form for treating or preventing hypertension and hyperlipidemia |